✦ LIBER ✦

PAR23 COST-UTILITY OF ABATACEPT, A NEW BIOLOGIC TREATMENT FOR PATIENTS WITH RHEUMATOID ARTHRITIS WHO FAILED ANTI-TNF THERAPY

✍ Scribed by NS Hawkins; K Minda; D Parry; P Hines; Y Yuan; R Maclean

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Biologica

✍ Ryazhenov, V.V.; Emchenko, I.V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS39 COST-UTILITY OF ABATACEPT IN RHEUM

✍ LG Mantovani; S De Portu; M Intorcia; I Olivieri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS33 COST EFFECTIVENESS OF ABATACEPT IN

✍ F. Becerra Rojas; C. Benites Chacaltana; E.C. Aiello; C. Zingoni; G. Bergman; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-minimisation analysis of subcutaneo

✍ Ray Fitzpatrick, David GI Scott, Ian Keary 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 235 KB